Osteosarcoma of the jaw/craniofacial region: Outcomes after multimodality treatment

Cancer

Volumn 115, Issue 14, 2009, Pages 3262-3270

  Guadagnolo, B Ashleigh ^a   Zagars, Gunar K ^a   Raymond, A Kevin ^a   Benjamin, Robert S ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Craniofacial bones; Jaw; Local control; Osteosarcoma; Radiotherapy

Indexed keywords

CISPLATIN; COBALT 60; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDITORY TUBE DYSFUNCTION; BONE GRAFT; BONE METASTASIS; BONE NECROSIS; BONE REMODELING; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CATARACT; CHILD; CHRONIC OTITIS MEDIA; CLINICAL EVALUATION; COBALT THERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FISTULA; GRAFT FAILURE; HEAD AND NECK TUMOR; HEARING LOSS; HEMIMANDIBULECTOMY; HUMAN; HYPERTROPHY; HYPOPITUITARISM; JAW OSTEOSARCOMA; KERATITIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALOCCLUSION; MANDIBLE RESECTION; MAXILLA RESECTION; MULTIMODALITY CANCER THERAPY; NERVE INJURY; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; SEROUS OTITIS MEDIA; SOFT TISSUE NECROSIS; SURGICAL TECHNIQUE; TISSUE NECROSIS; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JAW NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 68549120937     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24297     Document Type: Article

References (23)

1. Dahlin DC, Unni KK. Osteosarcoma Bone Tumors. Springfield, Ill: Charles C. Thomas Publisher; 1986:269-307.
2. Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol. 2003;15:239-252.
3. Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer. 1967;20:377-391.
4. Clark JL, Unni KK, Dahlin DC, Devine KD. Osteosarcoma of the jaw. Cancer. 1983;51:2311-2316.
5. Laskar S, Basu A, Muckaden MA, et al. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients. Head Neck. 2008;30:1020-1026.
6. Jasnau S, Meyer U, Potratz J, et al. Craniofacial osteosarcoma. Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol. 2008;44:286-294.
7. van Es RJ, Keus RB, van der Waal I, Koole R, Vermey A. Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg. 1997;26:191-197. (Pubitemid 127359658)
8. Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer. 2002;95:1495-1503.
9. CanadianSociety of Otolaryngology-Head and Neck Surgery Oncology Study Group. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol. 2004;33:139-144.
10. August M, Magennis P, Dewitt D. Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg. 1997;26:198-204. (Pubitemid 127359659)
11. Bertoni F, Dallera P, Bacchini P, Marchetti C, Campobassi A. The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer. 1991;68:1555-1563.
12. Ha PK, Eisele DW, Frassica FJ, Zahurak ML, McCarthy EF. Osteosarcoma of the head and neck: a review of the Johns Hopkins experience. Laryngoscope. 1999;109:964-969.
13. Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007;65:1286-1291. (Pubitemid 46915474)
14. Oda D, Bavisotto LM, Schmidt RA, et al. Head and neck osteosarcoma at the University of Washington. Head Neck. 1997;19:513-523. (Pubitemid 27349671)
15. Thiele OC, Freier K, Bacon C, Egerer G, Hofele CM. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study. Br J Oral Maxillofac Surg. 2008;46:533-536.
16. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Cox D. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
18. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol. 1997;15: 363-367.
19. Bruland OS, Hoifodt H, Saeter G, Smeland S, Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res. 2005;11:4666-4673.
20. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987;5:21-26. (Pubitemid 17007852)
21. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986; 314:1600-1606.
22. Link MP, Goorin AM, Horowitz M, et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991;(270):8-14.
23. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21:1574-1580. (Pubitemid 46594112)